What are the appropriate high‑flow oxygen (HFNC) parameters, including flow rate, FiO₂, temperature, and humidity, and how should they be titrated for a patient?

High-Flow Nasal Oxygen Parameters

Start HFNC at 60 L/min flow rate with FiO₂ titrated to achieve SpO₂ 94-98% (or 88-92% if risk of hypercapnia), with gas heated to 37°C and fully humidified. This represents the optimal initial setting based on physiological benefits and clinical outcomes 1, 2.

Initial Parameter Settings

Flow Rate

• Set at 60 L/min for most patients with acute respiratory failure
• This flow rate provides:
  • Adequate washout of anatomic dead space
  • Generation of low-level PEEP (approximately 7 cm H₂O at 50-60 L/min) 1
  • Minimal dilution of delivered FiO₂ by room air entrainment 3

Critical caveat: At flows below 60 L/min (particularly 20-40 L/min), the actual delivered FiO₂ can deviate significantly from the set FiO₂, especially with higher tidal volumes 4, 3. This means a patient may receive less oxygen than you think they're getting.

FiO₂ (Fraction of Inspired Oxygen)

• Initial FiO₂: Start at whatever concentration achieves your target saturation
• Target SpO₂ ranges:
  • 94-98% for patients WITHOUT risk of hypercapnic respiratory failure 1
  • 88-92% for patients at risk of hypercapnia (COPD, obesity hypoventilation, neuromuscular disease, chest wall deformities) 1

Titration approach:

• Adjust FiO₂ up or down in increments to maintain target saturation
• HFNC can deliver up to 100% FiO₂ 5, 1
• Recheck arterial blood gases 30-60 minutes after any increase in oxygen therapy, especially in hypercapnia-risk patients 1

Temperature

• Set at 37°C (body temperature) for optimal humidification 1

Important nuance: While 37°C provides physiologically appropriate conditions, research shows that 31°C may improve patient comfort without compromising clinical outcomes 6. However, in more severely hypoxemic patients (FiO₂ ≥45%), the combination of higher flow (60 L/min) AND higher temperature (37°C) actually improved comfort 6.

Practical recommendation: Start at 37°C, but if the patient complains of discomfort from heat, reducing to 31°C is reasonable and may improve tolerance.

Humidity

• Fully humidified (targeting 80-85% relative humidity at the set temperature) 1, 7
• This is automatically achieved by the heated humidifier component of HFNC systems
• Adequate humidification is essential to prevent airway drying and maintain mucociliary function 1

Titration Algorithm

Step 1: Assess Patient Risk Category

• No hypercapnia risk: Target SpO₂ 94-98%
• Hypercapnia risk (COPD, prior CO₂ retention, obesity, neuromuscular disease): Target SpO₂ 88-92% 1

Step 2: Initial Settings

• Flow: 60 L/min
• FiO₂: Start at 0.5-0.6 and titrate
• Temperature: 37°C
• Monitor SpO₂ continuously for first 5 minutes 1

Step 3: Titration Based on Response

If SpO₂ below target after 5 minutes:

• Increase FiO₂ in 0.1 increments
• If already at FiO₂ 1.0 and still hypoxemic, consider reservoir mask at 15 L/min or escalate to NIV/intubation 1
• Obtain arterial blood gas within 30-60 minutes 1

If SpO₂ above target:

• Decrease FiO₂ in 0.1 decrements
• For hypercapnia-risk patients: If SpO₂ >92%, reduce oxygen immediately and recheck blood gases 1

If patient reports discomfort:

• Consider reducing temperature to 31°C 6
• Verify proper prong size (should not occlude >50% of nares)
• Do NOT reduce flow rate below 60 L/min initially, as higher flow improves comfort in severe hypoxemia 6

Step 4: Monitoring

• First hour: SpO₂ continuously, vital signs every 15 minutes
• After stabilization: SpO₂ and vital signs every 4 hours 1
• Blood gases:
  • Within 30-60 minutes for all hypercapnia-risk patients 1
  • Repeat if clinical deterioration or increased oxygen requirements
  • NOT routinely needed for stable patients without hypercapnia risk 1

Clinical Context and Evidence Strength

HFNC vs. conventional oxygen: HFNC may reduce reintubation rates and improves patient comfort compared to conventional oxygen therapy post-extubation (low certainty evidence) 5.

HFNC vs. NIV: HFNC may reduce mortality, intubation, and hospital-acquired pneumonia compared to NIV for initial acute respiratory failure management, with better patient comfort 5. However, evidence certainty is low.

Post-extubation use: A recent trial showed no significant difference between 60 L/min vs. 40 L/min flow rates for preventing reintubation (22.1% vs. 16.9%, p=0.39), though 40 L/min required more escalation of support 8. This suggests starting at 60 L/min is safer to avoid the need for up-titration.

Common Pitfalls

1. Using flows <60 L/min initially: This results in unpredictable FiO₂ delivery, especially with variable tidal volumes 4, 3. You may think you're delivering 60% oxygen when the patient is only receiving 40%.

2. Forgetting blood gases in COPD patients: Even if initial PCO₂ is normal, it can rise with oxygen therapy. Always recheck at 30-60 minutes 1.

3. Over-oxygenating hypercapnia-risk patients: Keeping SpO₂ >92% in COPD patients increases risk of respiratory acidosis 1. Stick to 88-92%.

4. Assuming HFNC replaces NIV for hypercapnic respiratory failure: HFNC should NOT be used as primary therapy for acute hypercapnic respiratory failure with acidosis (pH <7.35) 1. These patients need NIV or intubation.

5. Not considering HFNC as alternative to reservoir mask: For acute hypoxemic respiratory failure without hypercapnia, HFNC is a reasonable alternative to high-flow reservoir masks and may be better tolerated 1.